MR mammography firm Caprius has settled a shareholder class-action suit filed in January 1998 that accused the Wilmington, MA, company of overstating revenues (SCAN 1/14/98). Caprius made a cash payment of $150,000, of which $100,000 was
MR mammography firm Caprius has settled a shareholder class-action suit filed in January 1998 that accused the Wilmington, MA, company of overstating revenues (SCAN 1/14/98). Caprius made a cash payment of $150,000, of which $100,000 was contributed by the company's insurance carrier. Caprius also issued 325,000 shares of stock to the plaintiffs and agreed to make an additional payment of $75,000 if it sells all or part of its business in the next 12 months.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
2 Commerce Drive
Cranbury, NJ 08512